☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

MHRA consult on OTC decongestants

The Medicines and Healthcare products Regulatory Agency has opened a public consultation on the proposal to restrict access to the availability of pseudoephedrine and ephedrine.

This consultation is in response to the Annual Report of the International Narcotics Control Board that identified that these medicines are used in the illegal manufacture of methylamphetamine, a Class A drug more commonly known as crystal meth.

Action: All healthcare professionals should be aware of the consultation and of the potential to illegally use pseudoephedrine and ephedrine in the manufacture of a Class A drug. Supplies of both drugs should be restricted to ensure inappropriate use is kept to a minimum.

Share 'MHRA consult on OTC decongestants' by emailShare 'MHRA consult on OTC decongestants' on FacebookShare 'MHRA consult on OTC decongestants' on TwitterShare 'MHRA consult on OTC decongestants' on MastodonShare 'MHRA consult on OTC decongestants' on LinkedInShare 'MHRA consult on OTC decongestants' on reddit

atomic-wealth

No Comments to “MHRA consult on OTC decongestants”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.